Ibtk - inhibitor of Bruton agammaglobulinemia tyrosine kinase

Predicted to enable protein kinase binding activity and protein tyrosine kinase inhibitor activity. Predicted to be involved in negative regulation of protein phosphorylation. Predicted to act upstream of or within release of sequestered calcium ion into cytosol. Predicted to be located in membrane. Predicted to be active in cytoplasm and nucleoplasm. Is expressed in early conceptus and genitourinary system. Orthologous to human IBTK (inhibitor of Bruton tyrosine kinase). [provided by Alliance of Genome Resources, Apr 2022]